Capabilities · Analytical & stability services

Container-closure integrity testing

A proposed analytical scope for assessing container-closure integrity, connecting intended presentation formats with appropriate physical or chemical test methods.

PlannedCatalogue scope

Illustrative unbranded autosampler vial detail.
Illustrative unbranded autosampler vial detail. It does not depict Luang Pharma's project, products or installed equipment.

Service statusPlanned

Planned.

Technical boundaries and readiness need confirmation before an activity could be presented as available.

Basis · Catalogue scope

Status
PlannedNo available service asserted
Source-plan relationship
Catalogue scopeProposed catalogue expansion
Readiness
Not establishedProduct and process evidence needed
Facility roadmap
First commercial batch target Q1 2028 · indicativeNot a service date

01 · Proposed service scope

Start with the product and its container.

Container-closure integrity testing is presented as a planned analytical domain. The specific product, presentation format and chosen analytical method would define the exact evaluation scope.

The initial Boten plan covers designated vial, ampoule and cartridge formats. The proposed integrity testing catalogue entry lies outside the initial plan and would need scope confirmation.

Probabilistic testing and deterministic methods represent distinct technical subjects. Listing this evaluation category does not establish which approach would be appropriate for a particular container system.

Catalogue boundary

A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.

02 · Presentation families

Match the route to the format.

Planned formats and their source relationship
FormatPlanning noteBasisStatus
Sterile liquid formatsAssessment formats for liquid presentations would require compatible test methods and validated detection limits.Catalogue scopePlanned
Lyophilised presentationsLyophilisation cycle developmentEvaluation of freeze-dried products would need approaches suited to reduced pressure or headspace composition.Catalogue scopePlanned
Multi-dose containersAssessment would consider repeated access and the relevant boundary definitions for ongoing physical integrity.Catalogue scopePlanned

03 · Process scope for discussion

Make the sequence and its evidence visible.

01 · Process stage

Planned

Method scope definition

Identification of the appropriate deterministic or probabilistic approach based on the specific container system.

02 · Process stage

Planned

Sample preparation requirements

Determination of how units would be presented, including any artificial defects required for evaluation.

03 · Process stage

Planned

Method development parameters

Establishment of specific parameters, detection limits and acceptance criteria for the intended analytical approach.

04 · Process stage

Planned

Validation protocol drafting

Preparation of the documentation required to qualify the selected testing approach against applicable compendial standards.

05 · Process stage

Planned

Analytical execution steps

Execution of the intended physical or chemical evaluation under defined laboratory conditions and controls.

06 · Process stage

Planned

Data review and reporting

Analysis of the generated instrument data and compilation of the resulting conclusions into a formal technical summary.

Illustrative sequence

This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.

04 · Supporting services

No service stands alone.

01PlannedCatalogue scope

Analytical method development

Product-specific test methods and analytical development questions.

Explore proposed scope

02PlannedInitial project scope

Aseptic filling of vials

Product preparation, filling, closure and visual-inspection scope.

Explore proposed scope

03PlannedCatalogue scope

Primary packaging

Blisters, bottles, sachets, tubes and presentation-specific container systems.

Explore proposed scope

05 · Readiness questions

A service claim needs a defined evidence base.

Presentation materials
Exact dimensions, material properties and closure mechanisms for the proposed packaging.
Facility and instruments
Relevant installed analytical equipment, qualification and an approved scope.
Method evidence
Defined parameters, appropriate validation ranges and the required limits of detection.
Quality responsibilities
Controlled data capture, analytical scope, review procedures and decision boundaries.
Regulatory context
Applicable compendial expectations for the intended presentation format and analytical strategy.
Technical agreement
Responsibilities, data disclosure and boundaries for any future testing engagement.

06 · Practical questions

Before a technical discussion.

Is this service currently available?

No. The service is Planned. This page is a scope proposal and does not establish an operating container-closure integrity testing service.

Which product types are in scope?

The proposed domain could consider various sterile presentations. The exact container, closure system and product state would define the appropriate strategy.

What information helps define the question?

Identify the intended container system, product state, development stage and the specific technical question. Confidential data should only be shared through an agreed route.

Is there a service launch quarter?

No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual service to a start date.

Does a technical discussion establish supply?

No. Feasibility, technical scope, required permissions, method evidence and an agreement would need to be established before any testing commitment.

Back to capabilities

Professional enquiries

Discuss a defined question.

Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.

Contact Luang Pharma